2005
DOI: 10.1097/01.mlg.0000157283.73284.a1
|View full text |Cite
|
Sign up to set email alerts
|

Prospective Phase II Trial of Concomitant Boost Radiotherapy For Stage II Nasopharyngeal Carcinoma: An Evaluation of Response and Toxicity

Abstract: This C-Boost radiotherapy regimen administers a substantially higher biologically effective dose compared with conventional radiation schedules. Preliminary locoregional control and survival rates are promising with no significant acute and/or late toxicities.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 15 publications
0
6
0
Order By: Relevance
“…In one study, dysgeusia complaints seemed proportional to the RT dose to the parotid gland [2]. In another study which followed patients over time, the frequency of dysgeusia as a complaint decreased over time [22]. In all studies, the severity of dysgeusia was rated as mild [2,8,17,22,34].…”
Section: Head and Neck Radiotherapymentioning
confidence: 98%
See 1 more Smart Citation
“…In one study, dysgeusia complaints seemed proportional to the RT dose to the parotid gland [2]. In another study which followed patients over time, the frequency of dysgeusia as a complaint decreased over time [22]. In all studies, the severity of dysgeusia was rated as mild [2,8,17,22,34].…”
Section: Head and Neck Radiotherapymentioning
confidence: 98%
“…In all studies, the severity of dysgeusia was rated as mild [2,8,17,22,34]. In four before and after (i.e., quasi-experimental, noncontrolled, non-randomized) studies involving RT alone, the rate of dysgeusia ranged from 16-100% [7,8,19,22] and was usually reported as mild to moderate in severity.…”
Section: Head and Neck Radiotherapymentioning
confidence: 99%
“…It is well accepted that larger tumor volumes represent increased tumor clonogens and hypoxia which may be the direct cause of reduced radiation efficacy, 8–11 and the prognostic value of tumor volume has also been suggested in several retrospective studies for nasopharyngeal cancer 12–16 . It has been recognized that local control of nasopharyngeal cancer is associated with radiation dose used, and unconventional radiotherapy modality with higher biological equivalent dose, such as brachytherapy and accelerated hyperfractionated concomitant boost radiation, may further improve treatment outcome 17,18 . However, the predictive value of primary tumor volume [gross tumor volume of the primary site (GTV‐P) in our study] on patients' prognosis after radiotherapy, particularly with higher biological equivalent doses, has never been studied in a prospective fashion.…”
Section: Introductionmentioning
confidence: 99%
“…Post‐RT symptom clusters differ depending on disease stage (Wu et al, ). In terms of acute radiation toxicity, the most frequent complication is mucositis in the second and third weeks of treatment (Lu et al, ). Additional acute RT‐related symptoms include appearance changes, severe oral‐pharyngeal pain, dry mouth, difficulty swallowing, difficulty opening one's mouth, hearing loss, changes in taste sensation and dermatitis (grade 1 or 2) (Giro et al, ; Huang, Wilkie, Chapman, & Ting, ; Huang, Wilkie, Schubert, & Ting, ; Koutcher, Wolden, & Lee, ; Lai et al, ).…”
Section: Introductionmentioning
confidence: 99%